file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012 | |
Word(i) List (4568) Word count: 24159, All words count: 34321 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
2001 | URETERAL | 5 | 1 | 34 |
2002 | ACTIVATE | 1 | 0 | 33 |
2003 | ANESTHETIC | 2 | 1 | 33 |
2004 | B-CELLS | 1 | 2 | 33 |
2005 | CELL-SPECIFIC | 1 | 18 | 33 |
2006 | CHROMOSOME | 4 | 1 | 33 |
2007 | CONVENTIONAL | 1 | 1 | 33 |
2008 | CROSS-REACTIVE | 1 | 3 | 33 |
2009 | DEFINITION | 1 | 6 | 33 |
2010 | DEOXYSPERGUALIN | 2 | 9 | 33 |
2011 | DULL | 1 | 2 | 33 |
2012 | GRAFTED | 3 | 3 | 33 |
2013 | HAMSTER-INTO-RAT | 1 | 2 | 33 |
2014 | HEALING | 1 | 0 | 33 |
2015 | HELPER | 2 | 5 | 33 |
2016 | IGD | 1 | 2 | 33 |
2017 | IGM | 1 | 2 | 33 |
2018 | IMMUNOCOMPETENT | 1 | 1 | 33 |
2019 | ISLET-DERIVED | 1 | 1 | 33 |
2020 | LONG-SURVIVING | 3 | 8 | 33 |
2021 | NVA2-CYCLOSPORINE | 1 | 5 | 33 |
2022 | PHOENIX | 1 | 0 | 33 |
2023 | PROMOTE | 1 | 0 | 33 |
2024 | PROXIMAL | 3 | 4 | 33 |
2025 | REPERTOIRE | 1 | 18 | 33 |
2026 | RISING | 1 | 0 | 33 |
2027 | TRANSFERRED | 4 | 4 | 33 |
2028 | TRANSGENIC | 5 | 12 | 33 |
2029 | UTERO | 2 | 1 | 33 |
2030 | ADVANCE | 1 | 0 | 32 |
# | Word | Recs | TLCS | TGCS |
2031 | ANTI-HOST | 1 | 1 | 32 |
2032 | BASELINE | 2 | 2 | 32 |
2033 | CHAPERONE | 2 | 8 | 32 |
2034 | CHOICE | 2 | 0 | 32 |
2035 | DEGRANULATION | 1 | 8 | 32 |
2036 | DENTAL | 2 | 2 | 32 |
2037 | FAILS | 1 | 15 | 32 |
2038 | HLA-HOMOZYGOUS | 1 | 11 | 32 |
2039 | HUMANIZED | 2 | 1 | 32 |
2040 | HYPEROSMOLAR | 1 | 9 | 32 |
2041 | IMMUNOPHENOTYPIC | 1 | 8 | 32 |
2042 | INFANT | 2 | 11 | 32 |
2043 | INTERFERON | 2 | 2 | 32 |
2044 | IONOPHORE-INDUCED | 1 | 8 | 32 |
2045 | LAG | 1 | 0 | 32 |
2046 | MEANS | 3 | 9 | 32 |
2047 | NEONATALLY | 1 | 15 | 32 |
2048 | NONKETOTIC | 1 | 9 | 32 |
2049 | OVERT | 1 | 0 | 32 |
2050 | PERSISTING | 2 | 1 | 32 |
2051 | PROLONGS | 6 | 3 | 32 |
2052 | RETINOPATHIES | 3 | 1 | 32 |
2053 | SELECTIVE-INHIBITION | 1 | 8 | 32 |
2054 | SENSITIZED | 5 | 10 | 32 |
2055 | SPITE | 2 | 19 | 32 |
2056 | STRUCTURAL-ANALYSIS | 1 | 8 | 32 |
2057 | TEMPO | 1 | 0 | 32 |
2058 | THERAPIES | 3 | 3 | 32 |
2059 | TOXICOSIS | 2 | 0 | 32 |
2060 | TUMOUR | 2 | 4 | 32 |
# | Word | Recs | TLCS | TGCS |
2061 | UNMODIFIED | 2 | 6 | 32 |
2062 | VENOOCCLUSIVE | 1 | 4 | 32 |
2063 | VETO | 1 | 1 | 32 |
2064 | 3-YEAR | 2 | 3 | 31 |
2065 | ABILITIES | 1 | 0 | 31 |
2066 | ANTIFUNGAL | 1 | 2 | 31 |
2067 | AUTO-AGRESSIVE | 1 | 8 | 31 |
2068 | CIS-TRANSISOMERIZATION | 1 | 0 | 31 |
2069 | COINCIDENT | 1 | 2 | 31 |
2070 | CONSEQUENCES | 1 | 0 | 31 |
2071 | DEFORMATION | 1 | 2 | 31 |
2072 | DESOLVATION | 1 | 0 | 31 |
2073 | DIFFER | 1 | 0 | 31 |
2074 | DISCREPANCIES | 1 | 1 | 31 |
2075 | EQUINE | 3 | 7 | 31 |
2076 | EQUITABLE | 1 | 8 | 31 |
2077 | EXTRARENAL | 1 | 8 | 31 |
2078 | FK-506-RESPONSIVE | 1 | 2 | 31 |
2079 | FKB1 | 1 | 2 | 31 |
2080 | GASTRODUODENAL | 1 | 0 | 31 |
2081 | GLUCOSE-INDUCED | 1 | 9 | 31 |
2082 | H-Y | 4 | 19 | 31 |
2083 | HAMSTER | 2 | 7 | 31 |
2084 | HEMOLYSIS | 2 | 3 | 31 |
2085 | IMMUNOSTIMULATORY | 2 | 1 | 31 |
2086 | IMMUNOSUPPRESSANT-FK506 | 1 | 9 | 31 |
2087 | LUNG-TRANSPLANT | 2 | 14 | 31 |
2088 | MALADIES | 2 | 8 | 31 |
2089 | MECHANISM-BASED | 2 | 7 | 31 |
2090 | MICROCHIMERIC | 5 | 9 | 31 |
# | Word | Recs | TLCS | TGCS |
2091 | MIZORIBINE | 1 | 4 | 31 |
2092 | MODELLING | 2 | 1 | 31 |
2093 | NEUROPSYCHIATRIC | 1 | 2 | 31 |
2094 | OVERCOME | 1 | 0 | 31 |
2095 | PATHOPHYSIOLOGY | 1 | 0 | 31 |
2096 | PROTEINURIA | 2 | 2 | 31 |
2097 | PSYCHOPHARMACOLOGY | 1 | 2 | 31 |
2098 | RODENTS | 3 | 7 | 31 |
2099 | SIMULTANEOUSLY | 3 | 2 | 31 |
2100 | SUPERIORITY | 2 | 19 | 31 |
2101 | SYNDROMES | 1 | 2 | 31 |
2102 | TEMPORAL | 2 | 2 | 31 |
2103 | TRAFFIC | 3 | 6 | 31 |
2104 | TYPING | 6 | 4 | 31 |
2105 | UNCERTAINTIES | 1 | 1 | 31 |
2106 | YEAST | 1 | 2 | 31 |
2107 | BRAIN-STEM | 1 | 1 | 30 |
2108 | CARDIOPULMONARY | 1 | 0 | 30 |
2109 | CATS | 1 | 0 | 30 |
2110 | CEREBELLAR | 1 | 1 | 30 |
2111 | COMPRESSION | 1 | 1 | 30 |
2112 | DOMESTIC | 1 | 0 | 30 |
2113 | EDEMA | 1 | 1 | 30 |
2114 | FELODIPINE-INDUCED | 1 | 3 | 30 |
2115 | FUNCTIONAL-DIFFERENTIATION | 1 | 4 | 30 |
2116 | GLYCEMIA | 1 | 21 | 30 |
2117 | GLYCOGEN | 2 | 0 | 30 |
2118 | GOODPASTURES | 1 | 1 | 30 |
2119 | GUINEA | 2 | 4 | 30 |
2120 | HISTOLOGIC-STUDY | 1 | 3 | 30 |
# | Word | Recs | TLCS | TGCS |
2121 | INTERFERING | 2 | 4 | 30 |
2122 | LYMPHOBLAST | 2 | 12 | 30 |
2123 | MACROLIDES | 3 | 0 | 30 |
2124 | NEOPLASIA | 1 | 0 | 30 |
2125 | NEWER | 2 | 3 | 30 |
2126 | PCR-SSP | 2 | 11 | 30 |
2127 | RADIOLOGY | 2 | 3 | 30 |
2128 | RECOGNIZABLE | 1 | 4 | 30 |
2129 | RENAL-VEIN | 1 | 3 | 30 |
2130 | SEDIMENT | 1 | 3 | 30 |
2131 | SENIORS | 1 | 5 | 30 |
2132 | TRAUMATIC | 2 | 1 | 30 |
2133 | WINDOW | 2 | 0 | 30 |
2134 | ALFA | 1 | 2 | 29 |
2135 | ALLOGENEIC-SYNGENEIC | 1 | 0 | 29 |
2136 | ANAESTHESIA | 1 | 3 | 29 |
2137 | ANTIGEN-INDUCED | 3 | 1 | 29 |
2138 | APES | 1 | 5 | 29 |
2139 | EPITHELIA | 1 | 0 | 29 |
2140 | EXPANDS | 1 | 0 | 29 |
2141 | FACILITATE | 2 | 10 | 29 |
2142 | GLUCOSE-TOLERANCE | 1 | 19 | 29 |
2143 | GRAVITY | 1 | 0 | 29 |
2144 | LARYNX | 1 | 0 | 29 |
2145 | MICROVASCULARIZED | 1 | 17 | 29 |
2146 | MILD | 2 | 0 | 29 |
2147 | NEEDS | 2 | 0 | 29 |
2148 | NONIRRADIATED | 1 | 17 | 29 |
2149 | ORGAN-INDUCED | 1 | 16 | 29 |
2150 | PARTIALLY | 3 | 2 | 29 |
# | Word | Recs | TLCS | TGCS |
2151 | PNEUMONITIS | 1 | 0 | 29 |
2152 | PSORIATIC | 2 | 2 | 29 |
2153 | REGRESSION | 2 | 4 | 29 |
2154 | REPLANTATION | 1 | 0 | 29 |
2155 | REWARDING | 1 | 1 | 29 |
2156 | SKIN-LESIONS | 2 | 2 | 29 |
2157 | URGENCY | 1 | 0 | 29 |
2158 | ADSORPTION | 1 | 0 | 28 |
2159 | ANTI-A | 1 | 0 | 28 |
2160 | B10 | 1 | 5 | 28 |
2161 | CARDIOMYOPATHY | 1 | 0 | 28 |
2162 | CHOLANGIOCARCINOMA | 1 | 3 | 28 |
2163 | CIS | 1 | 0 | 28 |
2164 | CLOTRIMAZOLE | 2 | 4 | 28 |
2165 | COMPLEMENT-MEDIATED | 2 | 0 | 28 |
2166 | CONSTANT | 1 | 1 | 28 |
2167 | CYSTIC | 2 | 0 | 28 |
2168 | DEPENDENCE | 1 | 10 | 28 |
2169 | DUAL | 1 | 4 | 28 |
2170 | EXPRESS | 2 | 2 | 28 |
2171 | EXTREME | 1 | 1 | 28 |
2172 | EXTREMITY | 4 | 0 | 28 |
2173 | GRAIL | 3 | 3 | 28 |
2174 | HOLY | 3 | 3 | 28 |
2175 | IMMUNOADSORBENT | 1 | 0 | 28 |
2176 | LEGACY | 2 | 14 | 28 |
2177 | LEUKOREDUCTION | 1 | 1 | 28 |
2178 | MICROCHIMERISM-ASSOCIATED | 1 | 10 | 28 |
2179 | NATURAL-KILLER | 1 | 0 | 28 |
2180 | NUCLEIC | 3 | 1 | 28 |
# | Word | Recs | TLCS | TGCS |
2181 | PERIPARTUM | 1 | 0 | 28 |
2182 | PIVOTAL | 1 | 10 | 28 |
2183 | REFLUX | 2 | 0 | 28 |
2184 | RESCUES | 1 | 3 | 28 |
2185 | SHARING | 3 | 0 | 28 |
2186 | SLE | 1 | 1 | 28 |
2187 | SPECIMENS | 2 | 15 | 28 |
2188 | TRANS | 1 | 0 | 28 |
2189 | TRANSFUSIONS | 3 | 1 | 28 |
2190 | TRAUMA | 1 | 3 | 28 |
2191 | ABH | 1 | 0 | 27 |
2192 | ALLELIC | 1 | 3 | 27 |
2193 | ALLOTRANSPLANT | 1 | 0 | 27 |
2194 | ANTI-CD45 | 1 | 5 | 27 |
2195 | BIOASSAY | 1 | 15 | 27 |
2196 | CAUTIONARY | 1 | 11 | 27 |
2197 | COMPARTMENTALIZATION | 1 | 24 | 27 |
2198 | COMPLICATION | 4 | 3 | 27 |
2199 | DIURESIS | 2 | 4 | 27 |
2200 | GLYCOLIPID-BASED | 1 | 0 | 27 |